Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and l-arginine metabolism in mice
- 3 November 2017
- journal article
- research article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 74 (1) , 9-16
Abstract
Obesity is a risk factor for vascular endothelial cell dysfunction characterized by low-grade, chronic inflammation. Increased levels of arginase I and concomitant decreases in l-arginine bioavailability are known to play a role in the pathogenesis of vascular endothelial cell dysfunction. In the present study, we focused on changes in the systemic expression of arginase I as well as l-arginine metabolism in the pre-disease state of early obesity prior to the onset of atherosclerosis. C57BL/6 mice were fed a control diet (CD; 10% fat) or high-fat diet (HFD; 60% fat) for 8 weeks. The mRNA expression of arginase I in the liver, adipose tissue, aorta, and muscle; protein expression of arginase I in the liver and plasma; and systemic levels of l-arginine bioavailability and NO2− were assessed. HFD-fed mice showed early obesity without severe disease symptoms. Arginase I mRNA and protein expression levels in the liver were significantly higher in HFD-fed obese mice than in CD-fed mice. Arginase I levels were slightly increased, whereas l-arginine levels were significantly reduced, and these changes were followed by reductions in NO2− levels. Furthermore, hepatic arginase I levels positively correlated with plasma arginase I levels and negatively correlated with l-arginine bioavailability in plasma. These results suggested that increases in the expression of hepatic arginase I and reductions in plasma l-arginine and NO2− levels might lead to vascular endothelial dysfunction in the pre-disease state of early obesity.Keywords
Funding Information
- Japan Society for the Promotion of Science (15K08775, 26293152)
This publication has 42 references indexed in Scilit:
- Lessons from Mouse Models of High-Fat Diet-Induced NAFLDInternational Journal of Molecular Sciences, 2013
- Transcriptional regulation of macrophage arginase 1 expression and its role in atherosclerosisTrends in Cardiovascular Medicine, 2013
- Arginase Activities and Global Arginine Bioavailability in Wild-Type and ApoE-Deficient Mice: Responses to High Fat and High Cholesterol DietsPLOS ONE, 2010
- Arginase: an emerging key player in the mammalian immune systemBritish Journal of Pharmacology, 2009
- Diminished Global Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of Increased Cardiovascular RiskJACC, 2009
- Arginine metabolism and nutrition in growth, health and diseaseAmino Acids, 2008
- Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase ActivityCirculation Research, 2008
- Inflammation and metabolic disordersNature, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001